Paul Reider - Chief Commercial Officer at Coherus Oncology, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Issuer Symbol
CHRS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Paul Reider since 11 Mar 2025

Holdings reported by Paul Reider for Coherus Oncology, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 82,069 $114,076 $1.39 20 Jan 2025 Direct
Stock Option (Right to Buy) 160,000 03 Jan 2025 Direct Common Stock

Transactions reported by Paul Reider for Coherus Oncology, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.